Press Releases April 15, 2026 04:39 PM

Sezzle to Announce First Quarter 2026 Results and Participate in Upcoming Investor Events

Sezzle to Release Q1 2026 Earnings and Engage in Major Investor Conferences

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
SEZL

Sezzle Inc. announced it will release its first quarter 2026 financial results on May 6, 2026, followed by a conference call and webcast. The company also plans to participate in several upcoming investor events throughout May and June 2026. Sezzle is a digital payment platform focused on providing point-of-sale financing and digital payment services to consumers and merchants.

Sezzle to Announce First Quarter 2026 Results and Participate in Upcoming Investor Events
SEZL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Sezzle will announce Q1 2026 earnings after market close on May 6, 2026, with a conference call and webcast scheduled.
  • Management will participate in multiple high-profile investor conferences in the technology, media, and consumer sectors.
  • Sezzle's platform enhances consumer purchasing power through point-of-sale financing and digital payment solutions, targeting financial empowerment of next-generation consumers.

Minneapolis, MN, April 15, 2026 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, will release its first quarter 2026 results after the market close on May 6, 2026. The Company will host a conference call and webcast at 5:00pm ET that same day. The earnings presentation will be available shortly after market close, via the Company’s Investor Relations page. Investors are encouraged to submit questions in advance of the call by emailing: [email protected].

 

Conference Call Registration

Participants can register for the conference call or webcast by navigating to:

https://dpregister.com/sreg/10208550/103e1a867dc

 

Upon registration, attendees will receive dial-in credentials and a link to the live webcast. A replay will be available on the Investor Relations page following the call.

 

Upcoming Investor Events

Sezzle Management will participate in the following investor events:

  • May 14, 2026: 21st Annual Needham Technology, Media, & Consumer Conference.
  • May 18, 2026: J.P. Morgan 2026 Global Technology, Media, and Communications Conference.
  • May 20, 2026: B. Riley Securities 2026 Annual Investor Conference.
  • June 17, 2026: Needham Non-Deal Roadshow.
  • June 23, 2026: Northland Growth Conference 2026. 

The Company’s latest investor presentation will be available on its Investor Relations page ahead of the events.

 

Contact Information

Jack Fagan
Investor Relations
(651) 240-6001
[email protected] Erin Foran
Media Inquiries
(651) 403-2184
[email protected]  

 


About Sezzle Inc.

Sezzle is a forward-thinking fintech company committed to financially empowering the next generation. Through its purpose-driven payment platform, Sezzle enhances consumers' purchasing power by offering access to point-of-sale financing options and digital payment services—connecting millions of customers with its global network of merchants. Centered on transparency, inclusivity, and ease of use, Sezzle empowers consumers to manage spending responsibly, take charge of their finances, and achieve lasting financial independence.

 

For more information visit sezzle.com.


Risks

  • Earnings results may not meet market expectations which could negatively impact stock performance.
  • Participation in investor events does not guarantee positive investor sentiment or stock price appreciation.
  • Economic and regulatory changes in fintech or digital payment sectors could affect business operations and growth prospects.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026